Abstract

Endothelial cells (ECs) play a crucial role in the development and propagation of the severe COVID-19 stage as well as multiorgan dysfunction. It remains, however, controversial whether COVID-19-induced endothelial injury is caused directly by the infection of ECs with SARS-CoV-2 or via indirect mechanisms. One of the major concerns is raised by the contradictory data supporting or denying the presence of ACE2, the SARS-CoV-2 binding receptor, on the EC surface. Here, we show that primary human pulmonary artery ECs possess ACE2 capable of interaction with the viral Spike protein (S-protein) and demonstrate the crucial role of the endothelial glycocalyx in the regulation of the S-protein binding to ACE2 on ECs. Using force spectroscopy method, we directly measured ACE2- and glycocalyx-dependent adhesive forces between S-protein and ECs and characterized the nanomechanical parameters of the cells exposed to S-protein. We revealed that the intact glycocalyx strongly binds S-protein but screens its interaction with ACE2. Reduction of glycocalyx layer exposes ACE2 receptors and promotes their interaction with S-protein. These results indicate that the susceptibility of ECs to COVID-19 infection may depend on the glycocalyx condition.

Highlights

  • Endothelial cells (ECs) play a crucial role in the development and propagation of the severe COVID19 stage as well as multiorgan dysfunction

  • The staining confirmed the presence of angiotensinconverting enzyme 2 (ACE2) in human pulmonary artery ECs (HPAECs)

  • We confirmed the presence of ACE2 protein in ECs and revealed a significant role of the glycocalyx in the regulation of the binding of SARS-CoV-2 S-protein to the EC surface

Read more

Summary

Introduction

Endothelial cells (ECs) play a crucial role in the development and propagation of the severe COVID19 stage as well as multiorgan dysfunction It remains, controversial whether COVID-19induced endothelial injury is caused directly by the infection of ECs with SARS-CoV-2 or via indirect mechanisms. The mechanism of SARS-CoV-2-induced damage of ECs remains an open question, hypothesizing direct infection of ECs by the virus and their subsequent injury or indirect mechanisms originating, for example, from immune ­processes[16] This issue is fueled by contradictory data on the presence of ACE2 receptor on ­ECs4,16–23, and the potential viral infection of these ­cells[24,25,26,27]. The role of the glycocalyx in the binding of SARS-CoV-2 to endothelium and its relation to ACE2 binding is still unclear and understudied

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.